Xtandi (Astellas Pharma US, Inc.)
Welcome to the PulseAid listing for the Xtandi drug offered from Astellas Pharma US, Inc.. This Androgen Receptor Inhibitor [EPC],Androgen Receptor Antagonists [MoA],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Astellas Pharma US, Inc. |
| NON-PROPRIETARY NAME: | enzalutamide |
| SUBSTANCE NAME: | ENZALUTAMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Androgen Receptor Inhibitor [EPC],Androgen Receptor Antagonists [MoA],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-08-31 |
| END MARKETING DATE: | 0000-00-00 |
Xtandi HUMAN PRESCRIPTION DRUG Details:
| Item Description | Xtandi from Astellas Pharma US, Inc. |
| LABELER NAME: | Astellas Pharma US, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(mg/1) |
| START MARKETING DATE: | 2012-08-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0469-0125_fe99d292-cd9a-43c9-8d4d-7ded3c461767 |
| PRODUCT NDC: | 0469-0125 |
| APPLICATION NUMBER: | NDA203415 |
Other ENZALUTAMIDE Pharmaceutical Manufacturers / Labelers:
